Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting

NCT05059600 is registered in ClinicalTrials.gov with Supernus Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05059600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
Lead sponsor
Supernus Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 8, 2021
Completion date
July 14, 2022
Enrollment
52 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression